Biomedical Application of Research in Infe… SA
8.9 FTEBiomedical Application of Research in Infe… reported total assets of €3.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Oct 2026), with 8.9 full-time equivalents.
By total assets for 2025, Biomedical Application of Research in Infe… ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Biomedical Application of Research in Infe… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +230 % Total assets +40 % Headcount (avg FTE) -55 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biomedical Application of Research in Infe…'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Oct 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 28 Nov 2022
Biomedical Application of Research in Infe…'s financial analysis
- Solvency32.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biomedical Application of Research in Infe…
2 active director(s) in the register.
Biomedical Application of Research in Infe…'s shareholders and holdings →Biomedical Application of Research in Infe…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.471.036
- VAT number
- BE0475471036
- Peppol
- Registered · 0208:0475471036 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 13 Aug 2001
- Registered office
- 9052 Ghent
- Size
- Micro · 8.9 FTE
- Latest accounts
- 2025 · filed on 06 Oct 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Biomedical Application of Research in Infe… (SA) has been based in Ghent since 2001, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 615,041 € and equity of €1.20m; its revenue is not published. With 8.9 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biomedical Application of Research in Infe…
Companies in the same business, of comparable size and area, outside its group.
- Johan Debrabandere - Apotheker Klinisch Bioloog Diagnostic imaging services and medical laboratory activities Roeselare · balance sheet €3.32m
- Evipa Diagnostic imaging services and medical laboratory activities Beveren-Kruibeke-Zwijndrecht · balance sheet €1.96m
- Niels Graindor Diagnostic imaging services and medical laboratory activities Landen · balance sheet €1.21m
- HemChem Diagnostic imaging services and medical laboratory activities Wuustwezel · balance sheet 836,106 €
- Département autonome de Diagnostic par Radio-isotopes All other professional, scientific and technical activities n.e.c. Uccle · balance sheet €3.63m
- Oncurious Diagnostic imaging services and medical laboratory activities Brussels · balance sheet 160,462 €
- Chrometra Diagnostic imaging services and medical laboratory activities Kortenaken · balance sheet 97,221 €
- FHP Diagnostic imaging services and medical laboratory activities Bornem · balance sheet 773,222 €
Frequently asked questions about Biomedical Application of Research in Infe…
What is the revenue of Biomedical Application of Research in Infe…?
Biomedical Application of Research in Infe… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biomedical Application of Research in Infe…?
In Belgium, the VAT number is the company number prefixed with BE: BE0475471036 for Biomedical Application of Research in Infe…, if the company is VAT-registered. Its company number (CBE) is 0475.471.036.
Where is the registered office of Biomedical Application of Research in Infe…?
According to the CBE register, the registered office of Biomedical Application of Research in Infe… is in 9052 Ghent.
What is the equity of Biomedical Application of Research in Infe…?
At the close of the 2025 financial year, the equity of Biomedical Application of Research in Infe… amounts to 1,201,783 €, a solvency of 32.5% of total assets.
How many people work at Biomedical Application of Research in Infe…?
8.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biomedical Application of Research in Infe…?
The register lists 2 active mandates at Biomedical Application of Research in Infe…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Biomedical Application of Research in Infe… within its sector?
By total assets for 2025, Biomedical Application of Research in Infe… ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Biomedical Application of Research in Infe…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →